Influence of smoking on disease severity and antimalarial therapy in cutaneous lupus erythematosus: analysis of 1002 patients from the EUSCLE database
British Journal of Dermatology2014Vol. 171(3), pp. 571–579
Citations Over TimeTop 10% of 2014 papers
Annegret Kuhn, Johanna Sigges, Cyrus Biazar, Vincent Ruland, Nikolaos Patsinakidis, Aysche Landmann, Susanne Amler, Gisela Bonsmann, the EUSCLE coauthors, Merle Haust, Fredrik Nyberg, Z. Bata, Lilla Mihályi, Rodica Olteanu, Ramón M. Pujol, Julia M. Sánchez‐Schmidt, Ljiljana Medenica, Dušan Škiljević, Adam Reich, Jacek C. Szepietowski, Camilla Dalle Vedove, Giampiero Girolomoni, Tomasz Hawro, Anna Zalewska‐Janowska, R. Glaeser, Rainer Huegel, Hana Jedličková, Anette Bygum, Rasa Laurinaviciene, Sandrine Benoit, E.‐B. Broecker, Friedrich A. Bahmer, Elisabeth Aberer, Nora Wutte, Jasna Lipozenčić, Branka Marinović, Miklós Sárdy, Vassiliki Bekou, Thomas Ruzicka, C. Francès, Boutros Soutou, H. Lee, Margitta Worm, A. Gruschke, N. Hunzelmann, Kerstin Steinbrink, Ricardo Romiti, Michael Sticherling, Cornelia Erfurt‐Berge, G. Avgerinou, Dafni Papafragkaki, Emiliano Antiga, Marzia Caproni, Benjamin Mayer, Beatrix Volc‐Platzer, Alexander Kreuter, Christian Tigges, Peter Maximilian Heil, Georg Stingl
Abstract
This analysis of a multicentre study population of 838 patients with CLE assessed by the EUSCLE Core Set Questionnaire confirms that smoking negatively influences CLE disease severity and the efficacy of antimalarial treatment.
Related Papers
- → Clinical manifestations of cutaneous lupus erythematosus(2005)175 cited
- → Cutaneous Manifestations of “Lupus”: Systemic Lupus Erythematosus and Beyond(2021)57 cited
- → Reply to: S2k guideline for treatment of cutaneous lupus erythematosus—guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)(2018)4 cited
- → Cutaneous lupus erythematosus: a great imitator(2011)2 cited
- → Cutaneous Lupus Erythematosus(2014)